000			01769 a2200457 4500
005			20250518044748.0
264		0	_c20200914
008			202009s 0 0 eng d
022			_a1179-1934
024	7		_a10.1007/s40263-019-00645-z _2doi
040			_aNLM _beng _cNLM
100	1		_aSurman, Craig B H
245	0	0	_aPost-Hoc Analyses of the Effects of Baseline Sleep Quality on SHP465 Mixed Amphetamine Salts Extended-Release Treatment Response in Adults with Attention-Deficit/Hyperactivity Disorder. _h[electronic resource]
260			_bCNS drugs _c07 2019
300			_a695-706 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAmphetamine _xtherapeutic use
650	0	4	_aAttention Deficit Disorder with Hyperactivity _xdrug therapy
650	0	4	_aCentral Nervous System Stimulants _xtherapeutic use
650	0	4	_aDelayed-Action Preparations _xtherapeutic use
650	0	4	_aDiagnostic and Statistical Manual of Mental Disorders
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aExecutive Function _xdrug effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPsychiatric Status Rating Scales
650	0	4	_aSalts _xtherapeutic use
650	0	4	_aSleep _xdrug effects
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aRobertson, Brigitte
700	1		_aChen, Jie
700	1		_aCortese, Samuele
773	0		_tCNS drugs _gvol. 33 _gno. 7 _gp. 695-706
856	4	0	_uhttps://doi.org/10.1007/s40263-019-00645-z _zAvailable from publisher's website
999			_c29824877 _d29824877